乳がん市場規模、シェア、成長分析、がんタイプ別、治療法別、エンドユーザー別、地域別 - 産業別予測、2024～2031年

乳がんの世界市場規模は2022年に319億米ドルとなり、予測期間（2024-2031年）のCAGRは10.4%で、2023年の352億米ドルから2031年には778億米ドルに成長する見通しです。

乳がん市場は、ライフスタイルの変化、高齢化、遺伝的要因、ホルモンバランスの乱れなどに起因する世界の罹患率の上昇により、力強い成長を遂げています。このような患者数の増加により、革新的な治療法や高度な診断ツールが求められています。分子イメージング、遺伝子検査、標的治療などの技術的進歩は、早期発見と治療成績を向上させ、市場の需要を煽っています。さらに、乳がんに対する意識の高まりは、早期発見を強調する政府のキャンペーンに支えられ、検診プログラムへの参加に拍車をかけています。しかし、特に低所得者層においては、治療費の高さがアクセスの障壁となるなどの課題も残っています。様々なサブタイプを持つ乳がんの複雑さは、治療の個別化を複雑にし、患者の転帰を最適化するための効率的な分子プロファイリングと遺伝子検査の必要性を強調しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーター分析と影響
  • 競争企業間の敵対関係
  • 代替品の脅威
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 供給企業の交渉力

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• エコシステムマッピング
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術評価
• 規制情勢
• 顧客と購買基準の分析
• パイプライン分析
• 疾病疫学
• 特許分析

乳がん市場規模：タイプ別

• 市場概要
• 浸潤性乳管がん
• 浸潤性小葉がん
• その他

乳がん市場規模：がんタイプ別

• 市場概要
• ホルモン受容体
• HER2+

乳がん市場規模：治療法別

• 市場概要
• 化学療法
  • 代謝拮抗物質
  • アントラサイクリン
  • タキサン
  • アルキル化剤
• 手術と放射線治療
• 標的療法
  • トロシンキナーゼ阻害剤
  • モノクローナル抗体
• 生物学的療法
• ホルモン療法
  • エストロゲン受容体調節薬
  • 芳香族阻害剤
  • その他

乳がん市場規模：エンドユーザー別

• 市場概要
• 病院薬局
• 小売薬局
• オンライン薬局
• その他

乳がん市場規模：地域別

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • スペイン
  • フランス
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021-2023）

主要企業プロファイル

• Pfizer Inc
• Novartis Ag
• F. Hoffmann-La Roche
• AstraZeneca Plc
• Glaxosmithkline
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceutical Industries
• Merck & Co
• Bristol Myers Squiib
• Kyowa Kirin
• Eisai Co.Ltd
• Sanofi
• Eli Lilly and Company
• Genentech, Inc.
• Roche Holding AG
• Johnson & Johnson
• AbbVie Inc.
• Daiichi Sankyo Company, Limited
• Amgen Inc.
• Celgene Corporation

結論と推奨事項

Global Breast Cancer Market size was valued at USD 31.9 billion in 2022 and is poised to grow from USD 35.2 billion in 2023 to USD 77.8 billion by 2031, growing at a CAGR of 10.4% during the forecast period (2024-2031).

The breast cancer market is experiencing robust growth due to rising global incidence rates, driven by lifestyle changes, aging, genetic factors, and hormonal imbalances. This increasing patient population demands innovative therapies and advanced diagnostic tools. Technological advancements, such as molecular imaging, genetic testing, and targeted therapies, enhance early detection and treatment outcomes, fueling market demand. Furthermore, heightened awareness about breast cancer has spurred participation in screening programs, supported by government campaigns emphasizing early detection. However, challenges persist, including the high costs of treatments, which pose barriers to access, particularly in low-income areas. The complexity of breast cancer, with its various subtypes, complicates treatment personalization, underscoring the need for efficient molecular profiling and genetic testing to optimize patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Cancer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Breast Cancer Market Segmental Analysis

Global Breast Cancer Market is segmented by Type, Cancer Type, Treatment, End User and Region. Based on Type, the market is segmented into Invasive Ductal Carcinoma, Invasive Lobular Carcinoma, Others. Based on Cancer Type, the market is segmented into Hormone Receptor, HER2+. Based on Treatment, the market is segmented into Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormonal Therapy. Based on End User, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Breast Cancer Market

The Global Breast Cancer market is significantly influenced by the rising awareness surrounding the disease and the critical importance of early detection. Efforts to educate the public about breast cancer have driven more individuals to engage in regular screenings and health check-ups. Various government initiatives, awareness campaigns, and the work of advocacy organizations are pivotal in promoting the significance of early diagnosis, which in turn bolsters the growth of the market. This comprehensive approach not only boosts participation in screening programs but also enhances overall understanding, leading to better health outcomes and fostering further development within the breast cancer sector.

Restraints in the Global Breast Cancer Market

The global breast cancer market faces significant restraints due to challenges in personalized medicine. Breast cancer is a complex and heterogeneous disease characterized by various subtypes, each exhibiting distinct treatment responses. This variability complicates the development of personalized treatment strategies, making it difficult to determine the most effective therapies for individual patients. As a result, the implementation of precision medicine in breast cancer care can be both challenging and time-consuming. This complexity hinders the broader adoption of tailored therapeutic approaches, ultimately impacting the market's growth potential and the advancement of innovative treatment options for patients.

Market Trends of the Global Breast Cancer Market

The global breast cancer market is increasingly characterized by the rise of targeted therapies, which have transformed treatment paradigms through their precision-driven approach. HER2-targeted therapies, including monoclonal antibodies and tyrosine kinase inhibitors, have markedly enhanced survival rates in HER2-positive cases and set a precedent for optimizing patient outcomes. Furthermore, the development of novel therapies targeting additional molecular abnormalities, such as PI3K and CDK4/6 inhibitors, is expanding treatment options and showing promise across various breast cancer subtypes. This shift towards personalized medicine is expected to drive market growth and foster innovation in therapeutic strategies, reflecting a broader commitment to improving care standards in oncology.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape
• Customer & Buying Criteria Analysis
• Pipeline Analysis
• Disease Epidemiology
• Patent Analysis

Global Breast Cancer Market Size by Type & CAGR (2024-2031)

• Market Overview
• Invasive Ductal Carcinoma
• Invasive Lobular Carcinoma
• Others

Global Breast Cancer Market Size by Cancer Type & CAGR (2024-2031)

• Market Overview
• Hormone Receptor
• HER2+

Global Breast Cancer Market Size by Treatment & CAGR (2024-2031)

• Market Overview
• Chemotherapy
  • Antimetabolites
  • Anthracyclines
  • Taxanes
  • Alkylating Agents
• Surgery & Radiation Therapy
• Targeted Therapy
  • Throsine Kinase Inhibitors
  • Monoclonal Antibodies
• Biologic Therapy
• Hormonal Therapy
  • Estrogen-Receptor Modulators
  • Aromatese Inhibitors
  • Others

Global Breast Cancer Market Size by End User & CAGR (2024-2031)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Breast Cancer Market Size & CAGR (2024-2031)

• North America (Type, Cancer Type, Treatment, End User)
  • US
  • Canada
• Europe (Type, Cancer Type, Treatment, End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (Type, Cancer Type, Treatment, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (Type, Cancer Type, Treatment, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Cancer Type, Treatment, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Pfizer Inc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis Ag
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca Plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glaxosmithkline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sun Pharmaceutical Industries Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bristol Myers Squiib
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kyowa Kirin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eisai Co.Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genentech, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Holding AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Daiichi Sankyo Company, Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celgene Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation